SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Stevens Helen E.) srt2:(2020-2023)"

Sökning: WFRF:(Stevens Helen E.) > (2020-2023)

  • Resultat 1-4 av 4
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Gafar, Fajri, et al. (författare)
  • Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents : a systematic review and individual patient data meta-analysis
  • 2023
  • Ingår i: European Respiratory Journal. - : European Respiratory Society. - 0903-1936 .- 1399-3003. ; 61:3
  • Forskningsöversikt (refereegranskat)abstract
    • Background Suboptimal exposure to antituberculosis (anti-TB) drugs has been associated with unfavourable treatment outcomes. We aimed to investigate estimates and determinants of first-line anti-TB drug pharmacokinetics in children and adolescents at a global level.Methods We systematically searched MEDLINE, Embase and Web of Science (1990–2021) for pharmacokinetic studies of first-line anti-TB drugs in children and adolescents. Individual patient data were obtained from authors of eligible studies. Summary estimates of total/extrapolated area under the plasma concentration–time curve from 0 to 24 h post-dose (AUC0–24) and peak plasma concentration (Cmax) were assessed with random-effects models, normalised with current World Health Organization-recommended paediatric doses. Determinants of AUC0–24 and Cmax were assessed with linear mixed-effects models.Results Of 55 eligible studies, individual patient data were available for 39 (71%), including 1628 participants from 12 countries. Geometric means of steady-state AUC0–24 were summarised for isoniazid (18.7 (95% CI 15.5–22.6) h·mg·L−1), rifampicin (34.4 (95% CI 29.4–40.3) h·mg·L−1), pyrazinamide (375.0 (95% CI 339.9–413.7) h·mg·L−1) and ethambutol (8.0 (95% CI 6.4–10.0) h·mg·L−1). Our multivariate models indicated that younger age (especially <2 years) and HIV-positive status were associated with lower AUC0–24 for all first-line anti-TB drugs, while severe malnutrition was associated with lower AUC0–24 for isoniazid and pyrazinamide. N-acetyltransferase 2 rapid acetylators had lower isoniazid AUC0–24 and slow acetylators had higher isoniazid AUC0–24 than intermediate acetylators. Determinants of Cmax were generally similar to those for AUC0–24.Conclusions This study provides the most comprehensive estimates of plasma exposures to first-line anti-TB drugs in children and adolescents. Key determinants of drug exposures were identified. These may be relevant for population-specific dose adjustment or individualised therapeutic drug monitoring.
  •  
2.
  • Leeksma, Alexander C., et al. (författare)
  • Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity : A multi-center study
  • 2020
  • Ingår i: Haematologica. - 0390-6078. ; 105:5
  • Tidskriftsartikel (refereegranskat)abstract
    • Complex karyotype (CK) identified by chromosome-banding analysis (CBA) has shown prognostic value in chronic lymphocytic leukemia (CLL). Genomic arrays offer high-resolution genome-wide detection of copy-number alterations (CNAs) and could therefore be well equipped to detect the presence of a CK. Current knowledge on genomic arrays in CLL is based on outcomes of single center studies, in which different cutoffs for CNA calling were used. To further determine the clinical utility of genomic arrays for CNA assessment in CLL diagnostics, we retrospectively analyzed 2293 arrays from 13 diagnostic laboratories according to established standards. CNAs were found outside regions captured by CLL FISH probes in 34% of patients, and several of them including gains of 8q, deletions of 9p and 18p (p<0.01) were linked to poor outcome after correction for multiple testing. Patients (n=972) could be divided in three distinct prognostic subgroups based on the number of CNAs. Only high genomic complexity (high-GC), defined as 5 CNAs emerged as an independent adverse prognosticator on multivariable analysis for time to first treatment (Hazard ratio: 2.15, 95% CI: 1.36-3.41; p=0.001) and overall survival (Hazard ratio: 2.54, 95% CI: 1.54-4.17; p<0.001; n=528). Lowering the size cutoff to 1 Mb in 647 patients did not significantly improve risk assessment. Genomic arrays detected more chromosomal abnormalities and performed at least as well in terms of risk stratification compared to simultaneous chromosome banding analysis as determined in 122 patients. Our findings highlight genomic array as an accurate tool for CLL risk stratification.
  •  
3.
  • Martin, Maria A., et al. (författare)
  • Ten new insights in climate science 2021 : a horizon scan
  • 2021
  • Ingår i: Global Sustainability. - : Cambridge University Press (CUP). - 2059-4798. ; 4, s. 1-20
  • Forskningsöversikt (refereegranskat)abstract
    • Non-technical summary: We summarize some of the past year's most important findings within climate change-related research. New research has improved our understanding about the remaining options to achieve the Paris Agreement goals, through overcoming political barriers to carbon pricing, taking into account non-CO2 factors, a well-designed implementation of demand-side and nature-based solutions, resilience building of ecosystems and the recognition that climate change mitigation costs can be justified by benefits to the health of humans and nature alone. We consider new insights about what to expect if we fail to include a new dimension of fire extremes and the prospect of cascading climate tipping elements.Technical summary: A synthesis is made of 10 topics within climate research, where there have been significant advances since January 2020. The insights are based on input from an international open call with broad disciplinary scope. Findings include: (1) the options to still keep global warming below 1.5 °C; (2) the impact of non-CO2 factors in global warming; (3) a new dimension of fire extremes forced by climate change; (4) the increasing pressure on interconnected climate tipping elements; (5) the dimensions of climate justice; (6) political challenges impeding the effectiveness of carbon pricing; (7) demand-side solutions as vehicles of climate mitigation; (8) the potentials and caveats of nature-based solutions; (9) how building resilience of marine ecosystems is possible; and (10) that the costs of climate change mitigation policies can be more than justified by the benefits to the health of humans and nature.Social media summary: How do we limit global warming to 1.5 °C and why is it crucial? See highlights of latest climate science.
  •  
4.
  • Telloni, Daniele, et al. (författare)
  • Evolution of Solar Wind Turbulence from 0.1 to 1 au during the First Parker Solar Probe-Solar Orbiter Radial Alignment
  • 2021
  • Ingår i: Astrophysical Journal Letters. - : American Astronomical Society. - 2041-8205 .- 2041-8213. ; 912:2
  • Tidskriftsartikel (refereegranskat)abstract
    • The first radial alignment between Parker Solar Probe and Solar Orbiter spacecraft is used to investigate the evolution of solar wind turbulence in the inner heliosphere. Assuming ballistic propagation, two 1.5 hr intervals are tentatively identified as providing measurements of the same plasma parcels traveling from 0.1 to 1 au. Using magnetic field measurements from both spacecraft, the properties of turbulence in the two intervals are assessed. Magnetic spectral density, flatness, and high-order moment scaling laws are calculated. The Hilbert-Huang transform is additionally used to mitigate short sample and poor stationarity effects. Results show that the plasma evolves from a highly Alfvenic, less-developed turbulence state near the Sun, to fully developed and intermittent turbulence at 1 au. These observations provide strong evidence for the radial evolution of solar wind turbulence.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-4 av 4
Typ av publikation
tidskriftsartikel (2)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (4)
Författare/redaktör
Pihl, Erik (1)
Fisher, Eleanor (1)
Österborg, Anders (1)
Denti, Paolo (1)
Mansouri, Larry (1)
Winkelmann, Ricarda (1)
visa fler...
Svensson, Elin M., 1 ... (1)
Donald, Peter R. (1)
Chen, Deliang, 1961 (1)
Sterner, Thomas, 195 ... (1)
Swaminathan, Soumya (1)
de Wit, Thierry Dudo ... (1)
Baliakas, Panagiotis (1)
Rosenquist, Richard (1)
Stamatopoulos, Kosta ... (1)
Ghia, Paolo (1)
Davis, Zadie (1)
Pospisilova, Sarka (1)
Alffenaar, Jan-Wille ... (1)
Lorek, Sylvia (1)
Rogelj, Joeri (1)
Sorriso-Valvo, Luca (1)
Blenckner, Thorsten (1)
Rockström, Johan (1)
Barbany, Gisela (1)
Hansson, Lotta (1)
Wall, Meaghan (1)
Steinvall, Konrad (1)
Hashizume, Masahiro (1)
Thonicke, Kirsten (1)
Marino, Raffaele (1)
Donges, Jonathan F. (1)
Puiggros, Anna (1)
Nguyen-Khac, Florenc ... (1)
Plevova, Karla (1)
Moysiadis, Theodoros (1)
Strefford, Jonathan ... (1)
Oscier, David (1)
Espinet, Blanca (1)
Haferlach, Claudia (1)
Jarosova, Marie (1)
Leeksma, Alexander C ... (1)
Kater, Arnon P. (1)
Mellink, Clemens (1)
Parker, Helen (1)
Schoumans, Jacquelin ... (1)
Lele, Sharachchandra (1)
Bastos, Ana (1)
Bale, Stuart D. (1)
Hirota, Marina (1)
visa färre...
Lärosäte
Uppsala universitet (2)
Göteborgs universitet (1)
Nordiska Afrikainstitutet (1)
Stockholms universitet (1)
Lunds universitet (1)
Språk
Engelska (4)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (2)
Medicin och hälsovetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy